Invesco Pharmaceuticals ETF
PJP
101 hedge funds and large institutions have $134M invested in Invesco Pharmaceuticals ETF in 2016 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 21 increasing their positions, 36 reducing their positions, and 10 closing their positions.
80% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 10
5% more funds holding
Funds holding: 96 → 101 (+5)
0.86% more ownership
Funds ownership: 14.98% → 15.84% (+0.86%)
12% less capital invested
Capital invested by funds: $152M → $134M (-$18M)
42% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 36
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
64% less call options, than puts
Call options by funds: $241K | Put options by funds: $668K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$6.23M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$2.3M |
| 3 |
Chevy Chase Trust
Bethesda,
Maryland
|
+$2.08M |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.78M |
| 5 |
Creative Planning
Overland Park,
Kansas
|
+$1.75M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$4.15M |
| 2 |
NFC
Northeast Financial Consultants
Westport,
Connecticut
|
-$3.48M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$2.93M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$2.69M |
| 5 |
VF
Virtu Financial
New York
|
-$2.44M |
PJP Hedge Fund Activity: Q4 2016 in Review
101 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Invesco Pharmaceuticals ETF (PJP) for Q4 2016, worth a combined $134M — down 12% from $152M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new PJP positions and 10 closed out — a net gain of 8 holders — while 21 added to existing stakes and 36 trimmed.
The largest buyer was Bank of America, adding an estimated $6.23M. The largest seller was Jane Street, cutting an estimated $4.15M.
- 101 institutional investors held Invesco Pharmaceuticals ETF (PJP) as of Q4 2016, up from 96 in Q3 2016.
- Funds reported $134M of Invesco Pharmaceuticals ETF stock for Q4 2016, down 12% quarter-over-quarter.
- 18 funds opened new Invesco Pharmaceuticals ETF positions in Q4 2016 and 10 closed out, a net change of +8 holders.
- The largest Invesco Pharmaceuticals ETF buyer in Q4 2016 was Bank of America, an estimated $6.23M added.
- The largest Invesco Pharmaceuticals ETF seller in Q4 2016 was Jane Street, an estimated $4.15M sold.
Based on aggregated 13F filings for Q4 2016.